SlideShare a Scribd company logo
CELL INJURY,ADAPTATION
AND DEATH
BPH 2.1 KIUT
Intro..
Cells are the basic units of tissues, which form organs and systems
in the human body.
• Cells are divided in to two main types:
1. Epithelial
2. Mesenchymal cells.
• In 1859, Virchow first published cellular theory of disease; concept that
diseases occur due to abnormalities at the level of cells.
• Since then, study of abnormalities in structure and function of cells in
disease has remained the focus of attention in understanding of diseases.
Thus, most forms of diseases begin with cell injury followed by consequent
loss of cellular function.
Human cell
Cellular responses to cell injury
1. Cell injury- the effect of a variety of stresses due to etiologic agents a cell
encounters resulting in changes in its internal and external env’nt.
2. Cell adaptation- Adjustments which the cells make in response to stresses
which may be for physiologic needs (physiologic adaptation) or a response to
non-lethal pathologic injury (pathologic adaptation).
3.Cell death is a state of irreversible injury. It may occur in the living body as a
local or focal change
Etiology (causes)of cell injury
Cells are broadly injured by two major ways:
•A. Genetic causes
•B. Acquired causes
Acquired causes of cell injury:
• 1. Hypoxia and ischemia e.g reduced blood-O2 supply to organ
• 2. Physical agents e.g mechanical trauma
• 3. Chemical agents and drugs e.g cyanide
• 4. Microbial agents e.g protozoa
• 5. Immunologic agents e.g hypersensitvity reaction
• 6. Nutritional derangements e.g deficiency
• 7. Ageing
• 8. Psychogenic diseases e.g mental disease
• 9. Iatrogenic factors i.e owing to the physician.
• 10. Idiopathic diseases. i.e unknown cause
Pathogenesis(mechanisms)of cell injury
•Injury to a normal cell by etiological agents can be;
1.Reversible
2.Irreversible
Mechanisms of cell injury
• Depletion of ATP
• Damage to mitochondria
• Influx of calcium with loss of calcium homeostasis
• Accumulation of oxygen derived free radicals
• Defects in membrane permeability
• Damage to DNA and proteins
Pathogenesis of Ischemia and Hypoxia cell injury.
(Biochemical and molecular changes)
•Ischemia and hypoxia are the most common forms of
cell injury.
•In Reversible cell injury If the ischemia or hypoxia is
of short duration, the effects may be reversible on
rapid restoration of circulation e.g. in coronary artery
occlusion, myocardial contractility, metabolism and
ultrastructures are reversed if the circulation is
quickly restored.
Mechanisms (Reversible cell injury)
1. Decreased generation of cellular ATP-necessary for cellular
functions protein synthesis, membrane transport, lipid synthesis
2. Intracellular lactic acidosis: Nuclear clumping
3. Damage to plasma membrane pumps: Hydropic swelling and
other membrane changes i.e Na+-K+ pump and Ca+ pump
4. Reduced protein synthesis: Dispersed ribosomes
• In Irreversible cell injury persistence of ischemia or hypoxia
results in irreversible damage to the structure and function of
the cell (cell death).
• Two essential phenomena distinguish irreversible from
reversible cell injury
1. Inability of the cell to reverse mitochondrial dysfunction on
reperfusion or re-oxygenation.
2. Disturbance in cell (plasma) membrane function.
Mechanisms (Irreversible cell injury)
1. Calcium influx: Mitochondrial damage-continued hypoxia leads to large influx of cytosolic
Ca+
2. Activated phospholipases: Membrane damage.
3. Intracellular proteases: Cytoskeletal damage
4. Activated endonucleases: Nuclear damage DNA or nucleoproteins are damaged by the
activated lysosomal enzymes such as proteases and endonucleases.
5. Lysosomal hydrolytic enzymes: Lysosomal damage, cell death and phagocytosis-e
hydrolytic enzymes: (e.g. hydrolase, RNAase, DNAase) on activation bring about enzymatic
digestion of cellular components and hence cell death.
Irreversible damage to the nucleus can be in three forms:…
i) Pyknosis: Condensation and clumping of nucleus which becomes dark
basophilic.
ii) Karyorrhexis: Nuclear fragmentation in to small bits dispersed in the
cytoplasm.
iii) Karyolysis: Dissolution of the nucleus.
Damaged DNA activates pro-apoptotic proteins leading the cell to death.
Common enzyme markers of cell death.
Ischemic-reperfusion injury and free radical
mediated cell injury.
• Depending upon the duration of ischemia/hypoxia, restoration of
blood flow may result in the following 3 different consequences
1. From ischemia to reversible injury
2. From ischemia to irreversible injury
3. From ischemia to reperfusion injury-somewhat longer reperfusion-
cell death.
• Ischemia-reperfusion injury occurs due to excessive accumulation of
free radicals or reactive oxygen species.
3 aspects are involved:
• 1. Calcium overload.
• 2. Excessive generation of free radicals (superoxide, H2O2, hydroxyl
radical, pernitrite)
• 3. Subsequent inflammatory reaction
Morphologic changes of reversible and irreversible cell
injury.
Common examples of morphologic forms of reversible cell
injury are under;
• 1. Hydropic change- accumulation of water in the cytoplasm of a cell(cloudy swelling)
• 2. Hyaline change- can be intracellular and extracellular
• 3. Mucoid change- Epithelial mucin and connective tissue mucin
• 4. Fatty change- intracellular accumulation of neutral fat
Hydropic change kidney. The tubular epithelial cells are distended with cytoplasmic
vacuoles while the interstitial vasculature is compressed. The nuclei of affected
tubules are pale
INTRACELLULAR ACCUMULATIONS
• Intracellular accumulation of substances in abnormal amounts occurs
within the cytoplasm (especially lysosomes) or nucleus of the cell.
Abnormal intracellular accumulations can be divided into 3 groups:
• i) Accumulation of constituents of normal cell metabolism produced in
excess e.g. accumulations of lipids (fatty change, cholesterol deposits),
proteins and carbohydrates.
• ii) Accumulation of abnormal substances produced as a result of abnormal
metabolism due to lack of some enzymes e.g. storage diseases or inborn
errors of metabolism.
• iii) Accumulation of pigments e.g. endogenous pigments under special
circumstances, and exogenous pigments due to lack of enzymatic
mechanisms to degrade the substances or transport them to other sites.
Morphological changes of irreversible cell injury.
•Cell death is a state of irreversible injury. It may occur
in the living body as a local or focal change
(i.e. autolysis, necrosis and apoptosis)
Changes that follow;
(i.e. gangrene and pathologic calcification),
or result in end of the life (somatic death).
1. AUTOLYSIS
•Autolysis (i.e. self-digestion) is disintegration of the cell by
its own hydrolytic enzymes liberated from lysosomes.
•Autolysis can occur;
• Living body surrounded by inflammatory reaction.
•Postmortem change in which there is complete absence of
surrounding inflammatory response.
Autolysis is rapid in some tissues rich in hydrolytic
enzymes.
• Pancreas,
• Gastric mucosa
Intermediate in tissues like;
• Heart
• Liver
• Kidney.
• Morphologically, identified by homogeneous and eosinophilic cytoplasm
with loss of cellular details and remains of cell as debris
2. NECROSIS
• Necrosis is defined as a localized area of death of tissue followed
later by degradation of tissue by hydrolytic enzymes liberated
from dead cells.
5 types of necrosis based on etiology and morphologic
appearance;
• Coagulative Necrosis
• Liquefaction Necrosis
• Caseous Necrosis
• Fat Necrosis
• Fibrinoid Necrosis
1. Coagulative Necrosis
•Most common type of necrosis caused by irreversible focal
injury, mostly from sudden cessation of blood flow.
(ischemic necrosis)
Organs commonly affected are the
•Heart
•Kidney
•Spleen.
• Grossly, focus of coagulative necrosis in the early stage is pale, firm, and slightly
swollen and is called infarct. With progression, the affected area becomes more
yellowish, softer, and shrunken.
• Microscopically, hallmark-conversion of normal cells into their ‘tomb stones’ i.e.
outlines of the cells are retained and the cell type can still be recognized but their
cytoplasmic and nuclear details are lost.
• The necrosed cells are swollen and have more eosinophilic cytoplasm than the
normal. These cells show nuclear changes of pyknosis, karyorrhexis and karyolysis.
2. Liquefaction Necrosis
•Commonly occurs due to ischemic injury and
bacterial or fungal infections.
•Hydrolytic enzymes in tissue degradation have a
dominant role in causing semi-fluid material.
Common examples are;
•Infarct brain
•Abscess cavity.
•Grossly, the affected area is soft with liquefied center
containing necrotic debris. Later, a cyst wall is formed.
•Microscopically, the cystic space contains necrotic cell
debris and macrophages filled with phagocytosed
material. The cyst wall is formed by proliferating
capillaries, inflammatory cells, and gliosis (proliferating
glial cells) in the case of brain and proliferating
fibroblasts in the case of abscess cavity
3. Caseous Necrosis
• Caseous (cheese-like)necrosis is found in the centre
of foci of tuberculous infections.
• It combines features of both coagulative and
liquefactive necrosis.
• Grossly, foci of caseous necrosis resemble dry cheese and
are soft, granular and yellowish. This appearance is partly
attributed to the histotoxic effects of lipopolysaccharides
present in the capsule of the tubercle bacilli,
Mycobacterium tuberculosis.
• Microscopically, centre of the necrosed focus contain
structureless, eosinophilic material having scattered
granular debris of disintegrated nuclei.
• The surrounding tissue shows characteristic
granulomatous inflammatory reaction consisting of
epithelioid cells (modified macro phages having
slipper-shaped vesicular nuclei), interspersed giant
cells of Langhans’ and foreign body type and
peripheral mantle of lymphocytes.
4. Fat Necrosis
•Fat necrosis is a special form of cell death occurring
at mainly fat-rich anatomic locations in the body.
•The examples are: traumatic fat necrosis of the
breast, especially in heavy and pendulous breasts,
and mesenteric fat necrosis due to acute
pancreatitis.
• Grossly, fat necrosis appears as yellowish-white and firm deposits.
Formation of calcium soaps imparts the necrosed foci firmer and
chalky white appearance.
• Microscopically, the necrosed fat cells have cloudy appearance and are
surrounded by an inflammatory reaction. Formation of calcium soaps is
identified in the tissue sections as amorphous, granular and basophilic
material.
5. Fibrinoid Necrosis
•Characterised by deposition of fibrin-like material which
has the staining properties of fibrin such as
phosphotungistic acid haematoxylin
•(PTAH) stain.
•It is encountered in various examples of immunologic
tissue injury (e.g. in immune complex vascu-litis,
autoimmune diseases), arterioles in hypertension,
peptic ulcer etc.
• Microscopically, fibrinoid necrosis is identified by brightly
eosinophilic, hyaline-like deposition in the vessel wall.
• Necrotic focus is surrounded by nuclear debris of neutrophils
(leucocytoclasis).
3. APOPTOSIS
•Apoptosis is a form of ‘coordinated and internally
programmed cell death’ having significance in a
variety of physiologic and pathologic conditions
(apoptosis=falling off or dropping off , as that of
leaves or petals). ‘cell suicide’.
•Unlike necrosis, apoptosis is not accompanied by any
inflammation and collateral tissue damage.
Apoptosis in biologic processes
• Apoptosis is responsible for mediating cell death in a wide
variety of physiologic and pathologic processes as under:
• Physiologic Processes:
• Organized cell destruction in sculpting of tissues during
development of embryo.
• Physiologic involution of cells in hormone-dependent tissues
e.g. endometrial shedding, regression of lactating breast after
withdrawal of breast-feeding.
• Normal cell destruction followed by replacement proliferation
such as in intestinal epithelium.
• Involution of the thymus in early age.
• Pathologic Processes:
• 1. Cell death in tumors exposed to chemotherapeutic agents.
• 2. Cell death by cytotoxic T cells in immune mechanisms such as in graft-versus-host
disease and rejection reactions.
• 3. Progressive depletion of CD4+T cells in the pathogenesis of AIDS.
• 4. Cell death in viral infections e.g. formation of Councilman bodies in viral
hepatitis.
• 5. Pathologic atrophy of organs and tissues on withdrawal of stimuli e.g. prostatic
atrophy after orchiectomy, atrophy of kidney or salivary gland on obstruction of
ureter or ducts, respectively.
• 6. Cell death in response to low dose of injurious agents involved in causation of
necrosis e.g. radiation, hypoxia and mild thermal injury.
• 7. In degenerative diseases of CNS e.g. in Alzheimer’s disease, Parkinson’s disease,
and chronic infective dementias.
• 8. Heart diseases e.g. in acute myocardial infarction (20% necrosis and 80%
apoptosis).
Morphologic features
1. Small clusters of cells in the background of viable cells.
2. Round to oval shrunken masses of intensely eosinophilic
cytoplasm (mummified cell) containing shrunken organelles
3.Pyknosis.
4. The cell membrane may show blebs or projections on the
surface.
5. Formation of membrane-bound near spherical bodies
containing condensed organelles around the cell called apoptotic
bodies.
6. No acute inflammatory reaction around apoptosis.
7. Phagocytosis of apoptotic bodies by macrophages.
Biochemical changes
• Proteolysis of cytoskeletal proteins.
• Protein-protein cross linkages.
• After initial pyknosis of nucleus, there is fragmentation of
chromatin by activation of nuclease.
• Appearance of phosphatidylserine on the outer surface of
cell membrane.
• Appearance of an adhesive glycoprotein thrombospondin
on the outer surface of apoptotic bodies.
• Appearance of phosphatidylserine and thrombospondin on
the outer surface of apoptotic cell facilitates early
recognition by macrophages for phagocytosis prior to
appearance of inflammatory cells.
Molecular mechanism
1. Initiators of apoptosis
i) Withdrawal of normal cell survival signals e.g. absence of certain
hormones, growth factors, cytokines.
ii) Agents of cell injury e.g. heat, radiation, hypoxia, toxins, free
radicals.
Apoptosis is mediated by caspases that activate proteases and
endonucleases,
• Caspases are activated by multiple pathways.
• 1. Intrinsic mitochondrial pathway
i. Cellular injury, DNA damage, or loss of hormonal stimulation leads to
inactivation of Bcl2.
ii. Lack of Bcl 2 allows cytochrome c to leak from the inner mitochondrial
matrix into the cytoplasm and activate caspases.
• 2. Extrinsic receptor-ligand pathway
i. FAS ligand binds FAS death receptor (CD95) on the target cell, activating
caspases (e.g., negative selection of thymocytes in thymus).
ii. Tumor necrosis factor (TNF) binds T N F receptor on the target cell,
activating caspases.
• 3. Cytotoxic CD8 + Tcell-mediated pathway
i. Perforins secreted by CD8 + T cell create pores in membrane of target cell,
ii. Granzyme from CD8 + T cell enters pores and activates caspases.
iii. CDS'" T-cell killing of virally infected cells is an example.
Molecular mechanism of Apoptosis
Changes after death
Two types of pathologic changes may superimpose
following cell injury
1. Gangrene (after necrosis)
2. Pathologic calcification.
1. Gangrene
• Gangrene is necrosis of tissue associated with superadded
putrefaction(decay accompanied by offensive smell), most often
following coagulative necrosis due to ischemia (e.g. in gangrene of the
bowel, gangrene of limb).
Two main types of gangrene—
• i) Dry
• Ii) Wet, and a variant of wet gangrene called gas gangrene.
i). Dry Gangrene
• This form of gangrene begins in the distal part of a limb due to
ischemia.
• The typical example is the dry gangrene in the toes and feet of an old
patient due to severe atherosclerosis.
• Other causes of dry gangrene foot include;
• Thromboangiitis obliterans (Buerger’s disease),
• Raynaud’s disease,
• Trauma,
• Ergot poisoning.
Morphologic features.
Grossly, the affected part is dry, shrunken and dark black, resembling the
foot of a mummy. It is black due to liberation of hemoglobin from
haemolysed red blood cells which is acted upon by hydrogen disulfide
(H2S) produced by bacteria resulting in formation of black iron sulfide.
Histologically, there is necrosis with smudging of the tissue. The line of
separation consists of inflammatory granulation tissue.
ii) Wet Gangrene
• Occurs in naturally moist tissues and organs such as the bowel, lung,
mouth, cervix, vulva etc.
Clinical significance are as follows:
• Diabetic foot which is due to high glucose content- favours growth
of bacteria.
• Bed sores occurring in a bed-ridden patient due to pressure on sites
like the sacrum, buttocks and heel.
Wet gangrene usually develops due to blockage of both venous as well as arterial
blood flow and is more rapid.
Morphologic features
Grossly, the affected part is soft, swollen, putrid, rotten and dark.
e.g is gangrene of the bowel, commonly due to strangulated hernia,
volvulus or intussusception.
The part is stained dark black due to the same mechanism as in dry
gangrene
Histologically, there is coagulative necrosis with stuffing of affected part
with blood. The mucosa is ulcerated and sloughed.
Lumen of the bowel contains mucus and blood. There is intense acute
inflammatory exudates and thrombosed vessels. The line of demarcation
between gangrenous segment and viable bowel is generally not clear-cut.
Gas gangrene
It is a special form of wet gangrene caused by gas-forming clostridia
(gram-positive anaerobic bacteria) of operation on colon which
normally contains clostridia.
• Clostridia produce various toxins which produce necrosis and edema
locally and are also absorbed producing profound systemic
manifestations.
• Grossly, the affected area is swollen, edematous, painful and
crepitant due to accumulation of gas bubbles of CO2 within the
tissues. Subsequently, the affected tissue becomes dark black and is
foul smelling.
.
• Microscopically, the muscle fibres undergo coaglative
necrosis with liquefaction. Large number of gram-
positive bacilli can be identified. At the periphery, a
zone of leucocytic infiltration, edema and congestion
are found. Capillary and venous thrombi are
common.
Pathologic calcifications
• Deposition of calcium salts in tissues other than osteoid or enamel is
called pathologic or heterotopic calcification.
1. Dystrophic calcification is characterised by deposition
of calcium salts in dead or degenerated tissues with normal calcium
metabolism and normal serum calcium level.
2. Metastatic calcification occurs in apparently normal tissues and is
associated with deranged calcium metabolism and hypercalcemia.
Cell Adaptation (Adaptation disorders)
-Adjustments which the cells make in response to stresses
which may be for physiologic needs (physiologic
adaptation) or a response to non-lethal pathologic injury
(pathologic adaptation).
-Adaptative dx are generally reversible with withdrawal of
stimulus but prolonged persistent irritant stimulus can lead
to cell death (atrophy) and carcinoma(dysplasia).
Adaptations occur by these processes;
• Atrophy
• Hypertrophy
• Hyperplasia
• Metaplasia
• Dysplasia
Mechanisms of adaptive cellular responses
•1. Altered cell surface receptor binding.
•2. Alterations in signal for protein synthesis.
•3. Synthesis of new proteins by the target cell.
1. Atrophy
• Reduction of the number and size of parenchymal cells of an organ or its
parts which was once normal.
Causes
• 1. Physiologic atrophy
• Atrophy is a normal process of ageing in some tissues, which could be due to
loss of endocrine stimulation or arteriosclerosis. For example:
• i) Atrophy of lymphoid tissue with age.
• ii) Atrophy of thymus in adult life.
• iii) Atrophy of gonads after menopause.
• iv) Atrophy of brain with ageing.
• v) Osteoporosis with reduction in size of bony trabeculae due
• to ageing.
• Pathologic atrophy
i). Starvation atrophy; In starvation cancer and severely ill patients.
ii). Ischemic atrophy; atherosclerosis may result in shrinkage of
organ.
iii). Disuse atrophy-Prolonged diminished use e.g Wasting of muscles
of limb immobilized in cast.
iv). Neuropathic atrophy- Poliomyelitis .
v). Endocrine atrophy-Hypopituitarism may lead to atrophy of thyroid,
adrenal and gonads.
vi). Pressure atrophy
vii). Idiopathic atrophy
2. Hypertrophy
Hypertrophy is an increase in the size of parenchymal cells resulting
in enlargement of the organ or tissue, without any change in the
number of cells.
Causes;
1. Physiologic hypertrophy
i) Enlarged size of the uterus in pregnancy
2.Pathologic
i). Hypertrophy of cardiac muscle- systemic hypertension
ii). Hypertrophy of smooth muscle e.g pyloric stenosis, strictures
iii) Hypertrophy of skeletal muscle e.g. in athletes, manual laborers.
iv) Compensatory hypertrophy may occur in an organ when the
contralateral organ is removed e.g. nephrectomy on one side in a pt.
• Morphological fx; The affected organ is enlarged and heavy.
E.g, a hypertrophied heart of a patient with systemic
hypertension.
• There is enlargement of muscle fibres as well as of nuclei.
At ultrastructural level, there is increased synthesis of DNA
and RNA, increased protein synthesis and increased
number of organelles such as mitochondria, endoplasmic
reticulum and myofibrils.
3. Hyperplasia
• Hyperplasia is an increase in the number of parenchymal cells
resulting in enlargement of the organ or tissue.
• Quite often, both hyperplasia and hypertrophy occur together.
Causes
• 1. Physiologic hyperplasia-(hormonal and compensatory):
a) Hormonal hyperplasia i.e influence of hormonal stimulation
• i) Hyperplasia of female breast at puberty, during pregnancy
• and lactation, pregnant uterus, prostatic hyperplasia
b) Compensatory hyperplasia i.e. hyperplasia occurring
following removal of part of an organ or in the contralateral
organ in paired organ e.g.
i) Regeneration of the liver following partial hepatectomy.
ii) Regeneration of epidermis after skin abrasion.
iii) Following nephrectomy on one side, there is hyperplasia of
nephrons of the other kidney
2. Pathologic hyperplasia-to excessive stimulation of hormones
or growth factors e.g.
i) Endometrial hyperplasia following estrogen excess.
ii) Formation of skin warts from hyperplasia of epidermis due to
human papilloma virus.
iv) Pseudocarcinomatous hyperplasia of the skin occurring at the
margin of a non-healing ulcer.
v) Intraductal epithelial hyperplasia in fibrocystic change in the
breast.
Morphologic fx; There is enlargement of the affected
organ or tissue and increase in the number of cells. This
is due to increased rate of DNA synthesis and hence
increased mitoses of the cells.
4. Metaplasia
Metaplasia is a reversible change of one type of epithelial or
mesenchymal adult cells to another type of adult epithelial or
mesenchymal cells, usually in response to abnormal stimuli, and
often reverts back to normal on removal of stimulus.
Long duration persistent stimulus, epithelial metaplasia may
progress to dysplasia and further into cancer.
2 types of metaplasia:
•Epithelial
•i) squamous metaplasia
•ii) columnar metaplasia
•Mesenchymal.
• a)Epithelial metaplasia.-More common type.
• The metaplastic change may be patchy or diffuse and
usually results in replacement by stronger but less well
specialized epithelium.
Two types of epithelial metaplasia are seen:
• squamous
•columnar
• 1. Squamous metaplasia; common-due to chronic irritation i.e
mechanical, chemical or infective in origin.
• Examples:
• i) In bronchus (normally lined by pseudostratified columnar ciliated epithelium)
in chronic smokers.
• ii) In uterine endocervix (normally lined by simple columnar epithelium) in
prolapse of the uterus and in old age.
• iii) In gallbladder (normally lined by simple columnar epithelium) in chronic
cholecystitis with cholelithiasis.
• iv) In prostate (ducts normally lined by simple columnar epithelium) in chronic
prostatitis and estrogen therapy.
• Columnar metaplasia; There are some conditions in which there is
transformation to columnar epithelium.
E.g
i) Intestinal metaplasia in healed chronic gastric ulcer
ii) Columnar metaplasia in Barrett’s oesophagus,
iii) Conversion of pseudostratified ciliated columnar epithelium in
chronic bronchitis and bronchiectasis to columnar type.
iv) In cervical erosion (congenital and adult type), there is variable area of
endocervical glandular mucosa everted into the vagina.
• b) Mesenchymal metaplasia-Less often, there is
transformation of one adult type of mesenchymal tissue to another.
• Example:
• 1. Osseous metaplasia; Osseous metaplasia is formation of bone in
fibrous tissue, cartilage and myxoid tissue.
E.g
• i) In arterial wall in old age (Mönckeberg’s medial calcific sclerosis)
• ii) In cartilage of larynx and bronchi in elderly people
• iii) In scar of chronic inflammation of prolonged duration
• iv) In the fibrous stroma of tumor e.g. in leiomyoma.
5.Dysplasia
• Dysplasia means ‘disordered cellular development’, often preceded or
accompanied with metaplasia and hyperplasia; (atypical hyperplasia).
• Dysplasia occurs most often in epithelial cells.
• Dysplastic changes often occur due to chronic irritation or prolonged
inflammation. On removal of the inciting stimulus, the changes may
disappear.
• Dysplasia may at times progress into carcinoma in situ.
Assignment
• Differences between Metaplasia and Dysplasia
• Read about Ageing.

More Related Content

What's hot

Mechanisms of cell injury
Mechanisms of cell injuryMechanisms of cell injury
Mechanisms of cell injury
Amnah Shaukat
 
Cell adaptation & Cell injury and Cell death
Cell adaptation & Cell injury and Cell deathCell adaptation & Cell injury and Cell death
Cell adaptation & Cell injury and Cell death
Rozzan Khatiwada
 
Hematopoiesis: Formation of Blood Cells - An Overview
Hematopoiesis: Formation of Blood Cells - An OverviewHematopoiesis: Formation of Blood Cells - An Overview
Hematopoiesis: Formation of Blood Cells - An Overview
StudyFriend
 
Cell aging
Cell agingCell aging
Cell aging
Microbiology
 
Necrosis and gangrene
Necrosis and gangreneNecrosis and gangrene
Necrosis and gangrene
Manoj Madakshira Gopal
 
Cell injury: CELL ADAPTATIONS
Cell injury: CELL ADAPTATIONSCell injury: CELL ADAPTATIONS
Cell injury: CELL ADAPTATIONS
Vijay Shankar
 
Introduction to pathology
Introduction to pathologyIntroduction to pathology
Introduction to pathologyGhie Santos
 
Bio 134 Pathology: Cell injury
Bio 134 Pathology: Cell injuryBio 134 Pathology: Cell injury
Bio 134 Pathology: Cell injury
Shaina Mavreen Villaroza
 
Hematopoisis
HematopoisisHematopoisis
Hematopoisis
Amen Ullah
 
Pathology of hemodynamic disorders Part 1 nov 2017 Sufia Husain
Pathology of hemodynamic disorders Part 1 nov 2017 Sufia HusainPathology of hemodynamic disorders Part 1 nov 2017 Sufia Husain
Pathology of hemodynamic disorders Part 1 nov 2017 Sufia Husain
Sufia Husain
 
Overview to Diagnosis of Acute leukemia
Overview to Diagnosis of Acute leukemiaOverview to Diagnosis of Acute leukemia
Overview to Diagnosis of Acute leukemia
Ahmed Makboul
 
cell necrosis , apoptosis presentation.pdf
cell necrosis , apoptosis presentation.pdfcell necrosis , apoptosis presentation.pdf
cell necrosis , apoptosis presentation.pdf
jasveer15
 
Haematopoiesis
HaematopoiesisHaematopoiesis
Haematopoiesis
Abdelwahab Khalid
 
LESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.ppt
LESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.pptLESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.ppt
LESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.ppt
mdaquib14
 
Metaplasia (1)
Metaplasia (1)Metaplasia (1)
Metaplasia (1)
Zainab&Sons
 
Hematopoiesis (Power Point Presentation)
Hematopoiesis (Power Point Presentation)   Hematopoiesis (Power Point Presentation)
Hematopoiesis (Power Point Presentation)
PRANJAL SHARMA
 
Hematopoiesis by SOlomon Suasb
Hematopoiesis by SOlomon SuasbHematopoiesis by SOlomon Suasb
Hematopoiesis by SOlomon Suasb
SOLOMON SUASB
 
Adaptation of cellular growth & differentiation
Adaptation of cellular growth & differentiationAdaptation of cellular growth & differentiation
Adaptation of cellular growth & differentiationHrudi Sahoo
 
Introduction to hematology
Introduction to hematologyIntroduction to hematology
Introduction to hematology
Juan Carlos Munévar
 
Cell Injury Patho
Cell Injury PathoCell Injury Patho
Cell Injury Pathoaxix
 

What's hot (20)

Mechanisms of cell injury
Mechanisms of cell injuryMechanisms of cell injury
Mechanisms of cell injury
 
Cell adaptation & Cell injury and Cell death
Cell adaptation & Cell injury and Cell deathCell adaptation & Cell injury and Cell death
Cell adaptation & Cell injury and Cell death
 
Hematopoiesis: Formation of Blood Cells - An Overview
Hematopoiesis: Formation of Blood Cells - An OverviewHematopoiesis: Formation of Blood Cells - An Overview
Hematopoiesis: Formation of Blood Cells - An Overview
 
Cell aging
Cell agingCell aging
Cell aging
 
Necrosis and gangrene
Necrosis and gangreneNecrosis and gangrene
Necrosis and gangrene
 
Cell injury: CELL ADAPTATIONS
Cell injury: CELL ADAPTATIONSCell injury: CELL ADAPTATIONS
Cell injury: CELL ADAPTATIONS
 
Introduction to pathology
Introduction to pathologyIntroduction to pathology
Introduction to pathology
 
Bio 134 Pathology: Cell injury
Bio 134 Pathology: Cell injuryBio 134 Pathology: Cell injury
Bio 134 Pathology: Cell injury
 
Hematopoisis
HematopoisisHematopoisis
Hematopoisis
 
Pathology of hemodynamic disorders Part 1 nov 2017 Sufia Husain
Pathology of hemodynamic disorders Part 1 nov 2017 Sufia HusainPathology of hemodynamic disorders Part 1 nov 2017 Sufia Husain
Pathology of hemodynamic disorders Part 1 nov 2017 Sufia Husain
 
Overview to Diagnosis of Acute leukemia
Overview to Diagnosis of Acute leukemiaOverview to Diagnosis of Acute leukemia
Overview to Diagnosis of Acute leukemia
 
cell necrosis , apoptosis presentation.pdf
cell necrosis , apoptosis presentation.pdfcell necrosis , apoptosis presentation.pdf
cell necrosis , apoptosis presentation.pdf
 
Haematopoiesis
HaematopoiesisHaematopoiesis
Haematopoiesis
 
LESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.ppt
LESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.pptLESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.ppt
LESSON 2-ACCUMULATION OF THE OF ENDOGENOUS AND EXOGENOUS PRODUCT_09091039.ppt
 
Metaplasia (1)
Metaplasia (1)Metaplasia (1)
Metaplasia (1)
 
Hematopoiesis (Power Point Presentation)
Hematopoiesis (Power Point Presentation)   Hematopoiesis (Power Point Presentation)
Hematopoiesis (Power Point Presentation)
 
Hematopoiesis by SOlomon Suasb
Hematopoiesis by SOlomon SuasbHematopoiesis by SOlomon Suasb
Hematopoiesis by SOlomon Suasb
 
Adaptation of cellular growth & differentiation
Adaptation of cellular growth & differentiationAdaptation of cellular growth & differentiation
Adaptation of cellular growth & differentiation
 
Introduction to hematology
Introduction to hematologyIntroduction to hematology
Introduction to hematology
 
Cell Injury Patho
Cell Injury PathoCell Injury Patho
Cell Injury Patho
 

Similar to CELL INJURY,ADAPTATION AND DEATH-2.1.pptx

Causesofcellinjury
Causesofcellinjury Causesofcellinjury
Causesofcellinjury
Sidal hospital
 
Causes of cell injury
Causes of cell injuryCauses of cell injury
Causes of cell injuryAj Cocjin
 
Cell injury
Cell injuryCell injury
Cell injury
sabahqaysar
 
Dr.Jasveer. cell injury presentation.pptx
Dr.Jasveer. cell injury presentation.pptxDr.Jasveer. cell injury presentation.pptx
Dr.Jasveer. cell injury presentation.pptx
jasveer15
 
DPT - Cell injury and Cell death
DPT - Cell injury and Cell deathDPT - Cell injury and Cell death
DPT - Cell injury and Cell death
Areesha Ahmad
 
Cell injury and cell death2
Cell injury and cell death2Cell injury and cell death2
Cell injury and cell death2
saskhaleed
 
Cell injury pathology
Cell injury pathology Cell injury pathology
Cell injury pathology
Akshatagrahari2
 
CELL INJURY-2 by DR. ROOPAM JAIN
CELL INJURY-2 by DR. ROOPAM JAINCELL INJURY-2 by DR. ROOPAM JAIN
CELL INJURY-2 by DR. ROOPAM JAIN
Dr. Roopam Jain
 
Regeneration & Degeneration
Regeneration & DegenerationRegeneration & Degeneration
Regeneration & DegenerationAFiFi Faridz
 
Cell injury & cell death
Cell injury & cell deathCell injury & cell death
Cell injury & cell death
Hassan Atheed
 
cell injury1.pptx
cell injury1.pptxcell injury1.pptx
cell injury1.pptx
SirnaEmana1
 
cell injury apotosis necrosis.pptx
cell injury apotosis necrosis.pptxcell injury apotosis necrosis.pptx
cell injury apotosis necrosis.pptx
Drmustafa Ali
 
lectureoncellinjury and adaptation-170214073507.pptx
lectureoncellinjury and adaptation-170214073507.pptxlectureoncellinjury and adaptation-170214073507.pptx
lectureoncellinjury and adaptation-170214073507.pptx
vandana thakur
 
Cell injury
Cell injuryCell injury
Cell injury
Ravish Yadav
 
lectureoncell (1).pptx
lectureoncell (1).pptxlectureoncell (1).pptx
lectureoncell (1).pptx
VandanaChandan1
 
lectureoncellinjury-170214073507.pptx
lectureoncellinjury-170214073507.pptxlectureoncellinjury-170214073507.pptx
lectureoncellinjury-170214073507.pptx
vandana thakur
 
cellinjury-190708093649.pdf
cellinjury-190708093649.pdfcellinjury-190708093649.pdf
cellinjury-190708093649.pdf
GaurishChandraRathau
 
Cell injury, Etiology, Pathogenesis, & Morphology of cell Injury
Cell injury, Etiology, Pathogenesis, & Morphology of cell InjuryCell injury, Etiology, Pathogenesis, & Morphology of cell Injury
Cell injury, Etiology, Pathogenesis, & Morphology of cell Injury
Dr. S N Medical College, Jodhpur
 
Degeneration, necrosis, and pathological pigmentation
Degeneration, necrosis, and pathological pigmentationDegeneration, necrosis, and pathological pigmentation
Degeneration, necrosis, and pathological pigmentationBruno Mmassy
 

Similar to CELL INJURY,ADAPTATION AND DEATH-2.1.pptx (20)

Causesofcellinjury
Causesofcellinjury Causesofcellinjury
Causesofcellinjury
 
Causes of cell injury
Causes of cell injuryCauses of cell injury
Causes of cell injury
 
Cell injury
Cell injuryCell injury
Cell injury
 
Dr.Jasveer. cell injury presentation.pptx
Dr.Jasveer. cell injury presentation.pptxDr.Jasveer. cell injury presentation.pptx
Dr.Jasveer. cell injury presentation.pptx
 
DPT - Cell injury and Cell death
DPT - Cell injury and Cell deathDPT - Cell injury and Cell death
DPT - Cell injury and Cell death
 
Cell injury and cell death2
Cell injury and cell death2Cell injury and cell death2
Cell injury and cell death2
 
Cell injury pathology
Cell injury pathology Cell injury pathology
Cell injury pathology
 
CELL INJURY-2 by DR. ROOPAM JAIN
CELL INJURY-2 by DR. ROOPAM JAINCELL INJURY-2 by DR. ROOPAM JAIN
CELL INJURY-2 by DR. ROOPAM JAIN
 
Regeneration & Degeneration
Regeneration & DegenerationRegeneration & Degeneration
Regeneration & Degeneration
 
Cell injury & cell death
Cell injury & cell deathCell injury & cell death
Cell injury & cell death
 
cell injury1.pptx
cell injury1.pptxcell injury1.pptx
cell injury1.pptx
 
cell injury apotosis necrosis.pptx
cell injury apotosis necrosis.pptxcell injury apotosis necrosis.pptx
cell injury apotosis necrosis.pptx
 
lectureoncellinjury and adaptation-170214073507.pptx
lectureoncellinjury and adaptation-170214073507.pptxlectureoncellinjury and adaptation-170214073507.pptx
lectureoncellinjury and adaptation-170214073507.pptx
 
Cell injury
Cell injuryCell injury
Cell injury
 
Cell injury
Cell injuryCell injury
Cell injury
 
lectureoncell (1).pptx
lectureoncell (1).pptxlectureoncell (1).pptx
lectureoncell (1).pptx
 
lectureoncellinjury-170214073507.pptx
lectureoncellinjury-170214073507.pptxlectureoncellinjury-170214073507.pptx
lectureoncellinjury-170214073507.pptx
 
cellinjury-190708093649.pdf
cellinjury-190708093649.pdfcellinjury-190708093649.pdf
cellinjury-190708093649.pdf
 
Cell injury, Etiology, Pathogenesis, & Morphology of cell Injury
Cell injury, Etiology, Pathogenesis, & Morphology of cell InjuryCell injury, Etiology, Pathogenesis, & Morphology of cell Injury
Cell injury, Etiology, Pathogenesis, & Morphology of cell Injury
 
Degeneration, necrosis, and pathological pigmentation
Degeneration, necrosis, and pathological pigmentationDegeneration, necrosis, and pathological pigmentation
Degeneration, necrosis, and pathological pigmentation
 

More from PharmTecM

dispersed system (ointment and bases).ppt
dispersed system (ointment and bases).pptdispersed system (ointment and bases).ppt
dispersed system (ointment and bases).ppt
PharmTecM
 
SEROTONIN for better understanding .pptx
SEROTONIN for better understanding .pptxSEROTONIN for better understanding .pptx
SEROTONIN for better understanding .pptx
PharmTecM
 
Eicosanoids mwisho.. For bettr understanding.pptx
Eicosanoids mwisho.. For bettr understanding.pptxEicosanoids mwisho.. For bettr understanding.pptx
Eicosanoids mwisho.. For bettr understanding.pptx
PharmTecM
 
CHOLINERGIC TRANSMISSION bph 23.pptx
CHOLINERGIC  TRANSMISSION bph 23.pptxCHOLINERGIC  TRANSMISSION bph 23.pptx
CHOLINERGIC TRANSMISSION bph 23.pptx
PharmTecM
 
14. infec desease.pptx
14. infec desease.pptx14. infec desease.pptx
14. infec desease.pptx
PharmTecM
 
Stereochemistry23-1.pptx
Stereochemistry23-1.pptxStereochemistry23-1.pptx
Stereochemistry23-1.pptx
PharmTecM
 
3 Enteric bacteria E.coli Klebsiella-1.pptx
3 Enteric bacteria E.coli Klebsiella-1.pptx3 Enteric bacteria E.coli Klebsiella-1.pptx
3 Enteric bacteria E.coli Klebsiella-1.pptx
PharmTecM
 
2 STREPTOCOCCI1 - ne.ppt
2 STREPTOCOCCI1 - ne.ppt2 STREPTOCOCCI1 - ne.ppt
2 STREPTOCOCCI1 - ne.ppt
PharmTecM
 
1 STAPHYLOCOCCUS.ppt
1 STAPHYLOCOCCUS.ppt1 STAPHYLOCOCCUS.ppt
1 STAPHYLOCOCCUS.ppt
PharmTecM
 
HYBRIDIZATION CHEMISTRY.pptx
HYBRIDIZATION CHEMISTRY.pptxHYBRIDIZATION CHEMISTRY.pptx
HYBRIDIZATION CHEMISTRY.pptx
PharmTecM
 
ANS PHARMACOLOGY BPH 2023.pptx
ANS PHARMACOLOGY BPH  2023.pptxANS PHARMACOLOGY BPH  2023.pptx
ANS PHARMACOLOGY BPH 2023.pptx
PharmTecM
 
Presentation1 NEOPLASIA III II YEAR UNDER - Copy_2.pptx
Presentation1  NEOPLASIA III    II  YEAR UNDER - Copy_2.pptxPresentation1  NEOPLASIA III    II  YEAR UNDER - Copy_2.pptx
Presentation1 NEOPLASIA III II YEAR UNDER - Copy_2.pptx
PharmTecM
 
STERILIZATION BY CHEMICAL METHODS.pptx
STERILIZATION BY CHEMICAL METHODS.pptxSTERILIZATION BY CHEMICAL METHODS.pptx
STERILIZATION BY CHEMICAL METHODS.pptx
PharmTecM
 
PCR LECTURE.ppt
PCR LECTURE.pptPCR LECTURE.ppt
PCR LECTURE.ppt
PharmTecM
 
lecture series-7-1.pptx
lecture series-7-1.pptxlecture series-7-1.pptx
lecture series-7-1.pptx
PharmTecM
 
CHEMISTRY NUCLEIC ACID.ppt
CHEMISTRY NUCLEIC ACID.pptCHEMISTRY NUCLEIC ACID.ppt
CHEMISTRY NUCLEIC ACID.ppt
PharmTecM
 
Nucleic Acid Chemistry session one.ppt
Nucleic Acid Chemistry session one.pptNucleic Acid Chemistry session one.ppt
Nucleic Acid Chemistry session one.ppt
PharmTecM
 
MALE&FEMALE REPROD.SYSTEMS.ppt
MALE&FEMALE REPROD.SYSTEMS.pptMALE&FEMALE REPROD.SYSTEMS.ppt
MALE&FEMALE REPROD.SYSTEMS.ppt
PharmTecM
 
HISTO. MALE&FEMALE GENITALS FINAL- DR G. TOWO.pptx
HISTO. MALE&FEMALE  GENITALS FINAL- DR G. TOWO.pptxHISTO. MALE&FEMALE  GENITALS FINAL- DR G. TOWO.pptx
HISTO. MALE&FEMALE GENITALS FINAL- DR G. TOWO.pptx
PharmTecM
 
Nucleic Acid Chemistry session one-1.ppt
Nucleic Acid Chemistry session one-1.pptNucleic Acid Chemistry session one-1.ppt
Nucleic Acid Chemistry session one-1.ppt
PharmTecM
 

More from PharmTecM (20)

dispersed system (ointment and bases).ppt
dispersed system (ointment and bases).pptdispersed system (ointment and bases).ppt
dispersed system (ointment and bases).ppt
 
SEROTONIN for better understanding .pptx
SEROTONIN for better understanding .pptxSEROTONIN for better understanding .pptx
SEROTONIN for better understanding .pptx
 
Eicosanoids mwisho.. For bettr understanding.pptx
Eicosanoids mwisho.. For bettr understanding.pptxEicosanoids mwisho.. For bettr understanding.pptx
Eicosanoids mwisho.. For bettr understanding.pptx
 
CHOLINERGIC TRANSMISSION bph 23.pptx
CHOLINERGIC  TRANSMISSION bph 23.pptxCHOLINERGIC  TRANSMISSION bph 23.pptx
CHOLINERGIC TRANSMISSION bph 23.pptx
 
14. infec desease.pptx
14. infec desease.pptx14. infec desease.pptx
14. infec desease.pptx
 
Stereochemistry23-1.pptx
Stereochemistry23-1.pptxStereochemistry23-1.pptx
Stereochemistry23-1.pptx
 
3 Enteric bacteria E.coli Klebsiella-1.pptx
3 Enteric bacteria E.coli Klebsiella-1.pptx3 Enteric bacteria E.coli Klebsiella-1.pptx
3 Enteric bacteria E.coli Klebsiella-1.pptx
 
2 STREPTOCOCCI1 - ne.ppt
2 STREPTOCOCCI1 - ne.ppt2 STREPTOCOCCI1 - ne.ppt
2 STREPTOCOCCI1 - ne.ppt
 
1 STAPHYLOCOCCUS.ppt
1 STAPHYLOCOCCUS.ppt1 STAPHYLOCOCCUS.ppt
1 STAPHYLOCOCCUS.ppt
 
HYBRIDIZATION CHEMISTRY.pptx
HYBRIDIZATION CHEMISTRY.pptxHYBRIDIZATION CHEMISTRY.pptx
HYBRIDIZATION CHEMISTRY.pptx
 
ANS PHARMACOLOGY BPH 2023.pptx
ANS PHARMACOLOGY BPH  2023.pptxANS PHARMACOLOGY BPH  2023.pptx
ANS PHARMACOLOGY BPH 2023.pptx
 
Presentation1 NEOPLASIA III II YEAR UNDER - Copy_2.pptx
Presentation1  NEOPLASIA III    II  YEAR UNDER - Copy_2.pptxPresentation1  NEOPLASIA III    II  YEAR UNDER - Copy_2.pptx
Presentation1 NEOPLASIA III II YEAR UNDER - Copy_2.pptx
 
STERILIZATION BY CHEMICAL METHODS.pptx
STERILIZATION BY CHEMICAL METHODS.pptxSTERILIZATION BY CHEMICAL METHODS.pptx
STERILIZATION BY CHEMICAL METHODS.pptx
 
PCR LECTURE.ppt
PCR LECTURE.pptPCR LECTURE.ppt
PCR LECTURE.ppt
 
lecture series-7-1.pptx
lecture series-7-1.pptxlecture series-7-1.pptx
lecture series-7-1.pptx
 
CHEMISTRY NUCLEIC ACID.ppt
CHEMISTRY NUCLEIC ACID.pptCHEMISTRY NUCLEIC ACID.ppt
CHEMISTRY NUCLEIC ACID.ppt
 
Nucleic Acid Chemistry session one.ppt
Nucleic Acid Chemistry session one.pptNucleic Acid Chemistry session one.ppt
Nucleic Acid Chemistry session one.ppt
 
MALE&FEMALE REPROD.SYSTEMS.ppt
MALE&FEMALE REPROD.SYSTEMS.pptMALE&FEMALE REPROD.SYSTEMS.ppt
MALE&FEMALE REPROD.SYSTEMS.ppt
 
HISTO. MALE&FEMALE GENITALS FINAL- DR G. TOWO.pptx
HISTO. MALE&FEMALE  GENITALS FINAL- DR G. TOWO.pptxHISTO. MALE&FEMALE  GENITALS FINAL- DR G. TOWO.pptx
HISTO. MALE&FEMALE GENITALS FINAL- DR G. TOWO.pptx
 
Nucleic Acid Chemistry session one-1.ppt
Nucleic Acid Chemistry session one-1.pptNucleic Acid Chemistry session one-1.ppt
Nucleic Acid Chemistry session one-1.ppt
 

Recently uploaded

BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 

Recently uploaded (20)

BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 

CELL INJURY,ADAPTATION AND DEATH-2.1.pptx

  • 2. Intro.. Cells are the basic units of tissues, which form organs and systems in the human body. • Cells are divided in to two main types: 1. Epithelial 2. Mesenchymal cells. • In 1859, Virchow first published cellular theory of disease; concept that diseases occur due to abnormalities at the level of cells. • Since then, study of abnormalities in structure and function of cells in disease has remained the focus of attention in understanding of diseases. Thus, most forms of diseases begin with cell injury followed by consequent loss of cellular function.
  • 4. Cellular responses to cell injury 1. Cell injury- the effect of a variety of stresses due to etiologic agents a cell encounters resulting in changes in its internal and external env’nt. 2. Cell adaptation- Adjustments which the cells make in response to stresses which may be for physiologic needs (physiologic adaptation) or a response to non-lethal pathologic injury (pathologic adaptation). 3.Cell death is a state of irreversible injury. It may occur in the living body as a local or focal change
  • 5.
  • 6. Etiology (causes)of cell injury Cells are broadly injured by two major ways: •A. Genetic causes •B. Acquired causes
  • 7. Acquired causes of cell injury: • 1. Hypoxia and ischemia e.g reduced blood-O2 supply to organ • 2. Physical agents e.g mechanical trauma • 3. Chemical agents and drugs e.g cyanide • 4. Microbial agents e.g protozoa • 5. Immunologic agents e.g hypersensitvity reaction • 6. Nutritional derangements e.g deficiency • 7. Ageing • 8. Psychogenic diseases e.g mental disease • 9. Iatrogenic factors i.e owing to the physician. • 10. Idiopathic diseases. i.e unknown cause
  • 8. Pathogenesis(mechanisms)of cell injury •Injury to a normal cell by etiological agents can be; 1.Reversible 2.Irreversible
  • 9. Mechanisms of cell injury • Depletion of ATP • Damage to mitochondria • Influx of calcium with loss of calcium homeostasis • Accumulation of oxygen derived free radicals • Defects in membrane permeability • Damage to DNA and proteins
  • 10. Pathogenesis of Ischemia and Hypoxia cell injury. (Biochemical and molecular changes) •Ischemia and hypoxia are the most common forms of cell injury. •In Reversible cell injury If the ischemia or hypoxia is of short duration, the effects may be reversible on rapid restoration of circulation e.g. in coronary artery occlusion, myocardial contractility, metabolism and ultrastructures are reversed if the circulation is quickly restored.
  • 11.
  • 12. Mechanisms (Reversible cell injury) 1. Decreased generation of cellular ATP-necessary for cellular functions protein synthesis, membrane transport, lipid synthesis 2. Intracellular lactic acidosis: Nuclear clumping 3. Damage to plasma membrane pumps: Hydropic swelling and other membrane changes i.e Na+-K+ pump and Ca+ pump 4. Reduced protein synthesis: Dispersed ribosomes
  • 13. • In Irreversible cell injury persistence of ischemia or hypoxia results in irreversible damage to the structure and function of the cell (cell death). • Two essential phenomena distinguish irreversible from reversible cell injury 1. Inability of the cell to reverse mitochondrial dysfunction on reperfusion or re-oxygenation. 2. Disturbance in cell (plasma) membrane function.
  • 14. Mechanisms (Irreversible cell injury) 1. Calcium influx: Mitochondrial damage-continued hypoxia leads to large influx of cytosolic Ca+ 2. Activated phospholipases: Membrane damage. 3. Intracellular proteases: Cytoskeletal damage 4. Activated endonucleases: Nuclear damage DNA or nucleoproteins are damaged by the activated lysosomal enzymes such as proteases and endonucleases. 5. Lysosomal hydrolytic enzymes: Lysosomal damage, cell death and phagocytosis-e hydrolytic enzymes: (e.g. hydrolase, RNAase, DNAase) on activation bring about enzymatic digestion of cellular components and hence cell death.
  • 15. Irreversible damage to the nucleus can be in three forms:… i) Pyknosis: Condensation and clumping of nucleus which becomes dark basophilic. ii) Karyorrhexis: Nuclear fragmentation in to small bits dispersed in the cytoplasm. iii) Karyolysis: Dissolution of the nucleus. Damaged DNA activates pro-apoptotic proteins leading the cell to death.
  • 16. Common enzyme markers of cell death.
  • 17. Ischemic-reperfusion injury and free radical mediated cell injury. • Depending upon the duration of ischemia/hypoxia, restoration of blood flow may result in the following 3 different consequences 1. From ischemia to reversible injury 2. From ischemia to irreversible injury 3. From ischemia to reperfusion injury-somewhat longer reperfusion- cell death.
  • 18. • Ischemia-reperfusion injury occurs due to excessive accumulation of free radicals or reactive oxygen species. 3 aspects are involved: • 1. Calcium overload. • 2. Excessive generation of free radicals (superoxide, H2O2, hydroxyl radical, pernitrite) • 3. Subsequent inflammatory reaction
  • 19. Morphologic changes of reversible and irreversible cell injury.
  • 20. Common examples of morphologic forms of reversible cell injury are under; • 1. Hydropic change- accumulation of water in the cytoplasm of a cell(cloudy swelling) • 2. Hyaline change- can be intracellular and extracellular • 3. Mucoid change- Epithelial mucin and connective tissue mucin • 4. Fatty change- intracellular accumulation of neutral fat
  • 21. Hydropic change kidney. The tubular epithelial cells are distended with cytoplasmic vacuoles while the interstitial vasculature is compressed. The nuclei of affected tubules are pale
  • 22. INTRACELLULAR ACCUMULATIONS • Intracellular accumulation of substances in abnormal amounts occurs within the cytoplasm (especially lysosomes) or nucleus of the cell. Abnormal intracellular accumulations can be divided into 3 groups: • i) Accumulation of constituents of normal cell metabolism produced in excess e.g. accumulations of lipids (fatty change, cholesterol deposits), proteins and carbohydrates. • ii) Accumulation of abnormal substances produced as a result of abnormal metabolism due to lack of some enzymes e.g. storage diseases or inborn errors of metabolism. • iii) Accumulation of pigments e.g. endogenous pigments under special circumstances, and exogenous pigments due to lack of enzymatic mechanisms to degrade the substances or transport them to other sites.
  • 23. Morphological changes of irreversible cell injury. •Cell death is a state of irreversible injury. It may occur in the living body as a local or focal change (i.e. autolysis, necrosis and apoptosis) Changes that follow; (i.e. gangrene and pathologic calcification), or result in end of the life (somatic death).
  • 24. 1. AUTOLYSIS •Autolysis (i.e. self-digestion) is disintegration of the cell by its own hydrolytic enzymes liberated from lysosomes. •Autolysis can occur; • Living body surrounded by inflammatory reaction. •Postmortem change in which there is complete absence of surrounding inflammatory response.
  • 25. Autolysis is rapid in some tissues rich in hydrolytic enzymes. • Pancreas, • Gastric mucosa Intermediate in tissues like; • Heart • Liver • Kidney. • Morphologically, identified by homogeneous and eosinophilic cytoplasm with loss of cellular details and remains of cell as debris
  • 26. 2. NECROSIS • Necrosis is defined as a localized area of death of tissue followed later by degradation of tissue by hydrolytic enzymes liberated from dead cells. 5 types of necrosis based on etiology and morphologic appearance; • Coagulative Necrosis • Liquefaction Necrosis • Caseous Necrosis • Fat Necrosis • Fibrinoid Necrosis
  • 27. 1. Coagulative Necrosis •Most common type of necrosis caused by irreversible focal injury, mostly from sudden cessation of blood flow. (ischemic necrosis) Organs commonly affected are the •Heart •Kidney •Spleen.
  • 28.
  • 29. • Grossly, focus of coagulative necrosis in the early stage is pale, firm, and slightly swollen and is called infarct. With progression, the affected area becomes more yellowish, softer, and shrunken. • Microscopically, hallmark-conversion of normal cells into their ‘tomb stones’ i.e. outlines of the cells are retained and the cell type can still be recognized but their cytoplasmic and nuclear details are lost. • The necrosed cells are swollen and have more eosinophilic cytoplasm than the normal. These cells show nuclear changes of pyknosis, karyorrhexis and karyolysis.
  • 30. 2. Liquefaction Necrosis •Commonly occurs due to ischemic injury and bacterial or fungal infections. •Hydrolytic enzymes in tissue degradation have a dominant role in causing semi-fluid material. Common examples are; •Infarct brain •Abscess cavity.
  • 31.
  • 32.
  • 33. •Grossly, the affected area is soft with liquefied center containing necrotic debris. Later, a cyst wall is formed. •Microscopically, the cystic space contains necrotic cell debris and macrophages filled with phagocytosed material. The cyst wall is formed by proliferating capillaries, inflammatory cells, and gliosis (proliferating glial cells) in the case of brain and proliferating fibroblasts in the case of abscess cavity
  • 34. 3. Caseous Necrosis • Caseous (cheese-like)necrosis is found in the centre of foci of tuberculous infections. • It combines features of both coagulative and liquefactive necrosis. • Grossly, foci of caseous necrosis resemble dry cheese and are soft, granular and yellowish. This appearance is partly attributed to the histotoxic effects of lipopolysaccharides present in the capsule of the tubercle bacilli, Mycobacterium tuberculosis.
  • 35. • Microscopically, centre of the necrosed focus contain structureless, eosinophilic material having scattered granular debris of disintegrated nuclei. • The surrounding tissue shows characteristic granulomatous inflammatory reaction consisting of epithelioid cells (modified macro phages having slipper-shaped vesicular nuclei), interspersed giant cells of Langhans’ and foreign body type and peripheral mantle of lymphocytes.
  • 36. 4. Fat Necrosis •Fat necrosis is a special form of cell death occurring at mainly fat-rich anatomic locations in the body. •The examples are: traumatic fat necrosis of the breast, especially in heavy and pendulous breasts, and mesenteric fat necrosis due to acute pancreatitis.
  • 37.
  • 38. • Grossly, fat necrosis appears as yellowish-white and firm deposits. Formation of calcium soaps imparts the necrosed foci firmer and chalky white appearance. • Microscopically, the necrosed fat cells have cloudy appearance and are surrounded by an inflammatory reaction. Formation of calcium soaps is identified in the tissue sections as amorphous, granular and basophilic material.
  • 39. 5. Fibrinoid Necrosis •Characterised by deposition of fibrin-like material which has the staining properties of fibrin such as phosphotungistic acid haematoxylin •(PTAH) stain. •It is encountered in various examples of immunologic tissue injury (e.g. in immune complex vascu-litis, autoimmune diseases), arterioles in hypertension, peptic ulcer etc.
  • 40. • Microscopically, fibrinoid necrosis is identified by brightly eosinophilic, hyaline-like deposition in the vessel wall. • Necrotic focus is surrounded by nuclear debris of neutrophils (leucocytoclasis).
  • 41. 3. APOPTOSIS •Apoptosis is a form of ‘coordinated and internally programmed cell death’ having significance in a variety of physiologic and pathologic conditions (apoptosis=falling off or dropping off , as that of leaves or petals). ‘cell suicide’. •Unlike necrosis, apoptosis is not accompanied by any inflammation and collateral tissue damage.
  • 42. Apoptosis in biologic processes • Apoptosis is responsible for mediating cell death in a wide variety of physiologic and pathologic processes as under: • Physiologic Processes: • Organized cell destruction in sculpting of tissues during development of embryo. • Physiologic involution of cells in hormone-dependent tissues e.g. endometrial shedding, regression of lactating breast after withdrawal of breast-feeding. • Normal cell destruction followed by replacement proliferation such as in intestinal epithelium. • Involution of the thymus in early age.
  • 43. • Pathologic Processes: • 1. Cell death in tumors exposed to chemotherapeutic agents. • 2. Cell death by cytotoxic T cells in immune mechanisms such as in graft-versus-host disease and rejection reactions. • 3. Progressive depletion of CD4+T cells in the pathogenesis of AIDS. • 4. Cell death in viral infections e.g. formation of Councilman bodies in viral hepatitis. • 5. Pathologic atrophy of organs and tissues on withdrawal of stimuli e.g. prostatic atrophy after orchiectomy, atrophy of kidney or salivary gland on obstruction of ureter or ducts, respectively. • 6. Cell death in response to low dose of injurious agents involved in causation of necrosis e.g. radiation, hypoxia and mild thermal injury. • 7. In degenerative diseases of CNS e.g. in Alzheimer’s disease, Parkinson’s disease, and chronic infective dementias. • 8. Heart diseases e.g. in acute myocardial infarction (20% necrosis and 80% apoptosis).
  • 44. Morphologic features 1. Small clusters of cells in the background of viable cells. 2. Round to oval shrunken masses of intensely eosinophilic cytoplasm (mummified cell) containing shrunken organelles 3.Pyknosis. 4. The cell membrane may show blebs or projections on the surface. 5. Formation of membrane-bound near spherical bodies containing condensed organelles around the cell called apoptotic bodies. 6. No acute inflammatory reaction around apoptosis. 7. Phagocytosis of apoptotic bodies by macrophages.
  • 45. Biochemical changes • Proteolysis of cytoskeletal proteins. • Protein-protein cross linkages. • After initial pyknosis of nucleus, there is fragmentation of chromatin by activation of nuclease. • Appearance of phosphatidylserine on the outer surface of cell membrane. • Appearance of an adhesive glycoprotein thrombospondin on the outer surface of apoptotic bodies. • Appearance of phosphatidylserine and thrombospondin on the outer surface of apoptotic cell facilitates early recognition by macrophages for phagocytosis prior to appearance of inflammatory cells.
  • 46. Molecular mechanism 1. Initiators of apoptosis i) Withdrawal of normal cell survival signals e.g. absence of certain hormones, growth factors, cytokines. ii) Agents of cell injury e.g. heat, radiation, hypoxia, toxins, free radicals. Apoptosis is mediated by caspases that activate proteases and endonucleases,
  • 47. • Caspases are activated by multiple pathways. • 1. Intrinsic mitochondrial pathway i. Cellular injury, DNA damage, or loss of hormonal stimulation leads to inactivation of Bcl2. ii. Lack of Bcl 2 allows cytochrome c to leak from the inner mitochondrial matrix into the cytoplasm and activate caspases. • 2. Extrinsic receptor-ligand pathway i. FAS ligand binds FAS death receptor (CD95) on the target cell, activating caspases (e.g., negative selection of thymocytes in thymus). ii. Tumor necrosis factor (TNF) binds T N F receptor on the target cell, activating caspases. • 3. Cytotoxic CD8 + Tcell-mediated pathway i. Perforins secreted by CD8 + T cell create pores in membrane of target cell, ii. Granzyme from CD8 + T cell enters pores and activates caspases. iii. CDS'" T-cell killing of virally infected cells is an example.
  • 49.
  • 50. Changes after death Two types of pathologic changes may superimpose following cell injury 1. Gangrene (after necrosis) 2. Pathologic calcification.
  • 51. 1. Gangrene • Gangrene is necrosis of tissue associated with superadded putrefaction(decay accompanied by offensive smell), most often following coagulative necrosis due to ischemia (e.g. in gangrene of the bowel, gangrene of limb). Two main types of gangrene— • i) Dry • Ii) Wet, and a variant of wet gangrene called gas gangrene.
  • 52. i). Dry Gangrene • This form of gangrene begins in the distal part of a limb due to ischemia. • The typical example is the dry gangrene in the toes and feet of an old patient due to severe atherosclerosis. • Other causes of dry gangrene foot include; • Thromboangiitis obliterans (Buerger’s disease), • Raynaud’s disease, • Trauma, • Ergot poisoning.
  • 53. Morphologic features. Grossly, the affected part is dry, shrunken and dark black, resembling the foot of a mummy. It is black due to liberation of hemoglobin from haemolysed red blood cells which is acted upon by hydrogen disulfide (H2S) produced by bacteria resulting in formation of black iron sulfide. Histologically, there is necrosis with smudging of the tissue. The line of separation consists of inflammatory granulation tissue.
  • 54. ii) Wet Gangrene • Occurs in naturally moist tissues and organs such as the bowel, lung, mouth, cervix, vulva etc. Clinical significance are as follows: • Diabetic foot which is due to high glucose content- favours growth of bacteria. • Bed sores occurring in a bed-ridden patient due to pressure on sites like the sacrum, buttocks and heel. Wet gangrene usually develops due to blockage of both venous as well as arterial blood flow and is more rapid.
  • 55. Morphologic features Grossly, the affected part is soft, swollen, putrid, rotten and dark. e.g is gangrene of the bowel, commonly due to strangulated hernia, volvulus or intussusception. The part is stained dark black due to the same mechanism as in dry gangrene Histologically, there is coagulative necrosis with stuffing of affected part with blood. The mucosa is ulcerated and sloughed. Lumen of the bowel contains mucus and blood. There is intense acute inflammatory exudates and thrombosed vessels. The line of demarcation between gangrenous segment and viable bowel is generally not clear-cut.
  • 56. Gas gangrene It is a special form of wet gangrene caused by gas-forming clostridia (gram-positive anaerobic bacteria) of operation on colon which normally contains clostridia. • Clostridia produce various toxins which produce necrosis and edema locally and are also absorbed producing profound systemic manifestations. • Grossly, the affected area is swollen, edematous, painful and crepitant due to accumulation of gas bubbles of CO2 within the tissues. Subsequently, the affected tissue becomes dark black and is foul smelling.
  • 57. . • Microscopically, the muscle fibres undergo coaglative necrosis with liquefaction. Large number of gram- positive bacilli can be identified. At the periphery, a zone of leucocytic infiltration, edema and congestion are found. Capillary and venous thrombi are common.
  • 58. Pathologic calcifications • Deposition of calcium salts in tissues other than osteoid or enamel is called pathologic or heterotopic calcification. 1. Dystrophic calcification is characterised by deposition of calcium salts in dead or degenerated tissues with normal calcium metabolism and normal serum calcium level. 2. Metastatic calcification occurs in apparently normal tissues and is associated with deranged calcium metabolism and hypercalcemia.
  • 59.
  • 60. Cell Adaptation (Adaptation disorders) -Adjustments which the cells make in response to stresses which may be for physiologic needs (physiologic adaptation) or a response to non-lethal pathologic injury (pathologic adaptation). -Adaptative dx are generally reversible with withdrawal of stimulus but prolonged persistent irritant stimulus can lead to cell death (atrophy) and carcinoma(dysplasia).
  • 61. Adaptations occur by these processes; • Atrophy • Hypertrophy • Hyperplasia • Metaplasia • Dysplasia
  • 62. Mechanisms of adaptive cellular responses •1. Altered cell surface receptor binding. •2. Alterations in signal for protein synthesis. •3. Synthesis of new proteins by the target cell.
  • 63. 1. Atrophy • Reduction of the number and size of parenchymal cells of an organ or its parts which was once normal. Causes • 1. Physiologic atrophy • Atrophy is a normal process of ageing in some tissues, which could be due to loss of endocrine stimulation or arteriosclerosis. For example: • i) Atrophy of lymphoid tissue with age. • ii) Atrophy of thymus in adult life. • iii) Atrophy of gonads after menopause. • iv) Atrophy of brain with ageing. • v) Osteoporosis with reduction in size of bony trabeculae due • to ageing.
  • 64. • Pathologic atrophy i). Starvation atrophy; In starvation cancer and severely ill patients. ii). Ischemic atrophy; atherosclerosis may result in shrinkage of organ. iii). Disuse atrophy-Prolonged diminished use e.g Wasting of muscles of limb immobilized in cast.
  • 65. iv). Neuropathic atrophy- Poliomyelitis . v). Endocrine atrophy-Hypopituitarism may lead to atrophy of thyroid, adrenal and gonads. vi). Pressure atrophy vii). Idiopathic atrophy
  • 66. 2. Hypertrophy Hypertrophy is an increase in the size of parenchymal cells resulting in enlargement of the organ or tissue, without any change in the number of cells. Causes; 1. Physiologic hypertrophy i) Enlarged size of the uterus in pregnancy
  • 67. 2.Pathologic i). Hypertrophy of cardiac muscle- systemic hypertension ii). Hypertrophy of smooth muscle e.g pyloric stenosis, strictures iii) Hypertrophy of skeletal muscle e.g. in athletes, manual laborers. iv) Compensatory hypertrophy may occur in an organ when the contralateral organ is removed e.g. nephrectomy on one side in a pt.
  • 68. • Morphological fx; The affected organ is enlarged and heavy. E.g, a hypertrophied heart of a patient with systemic hypertension. • There is enlargement of muscle fibres as well as of nuclei. At ultrastructural level, there is increased synthesis of DNA and RNA, increased protein synthesis and increased number of organelles such as mitochondria, endoplasmic reticulum and myofibrils.
  • 69.
  • 70. 3. Hyperplasia • Hyperplasia is an increase in the number of parenchymal cells resulting in enlargement of the organ or tissue. • Quite often, both hyperplasia and hypertrophy occur together. Causes • 1. Physiologic hyperplasia-(hormonal and compensatory): a) Hormonal hyperplasia i.e influence of hormonal stimulation • i) Hyperplasia of female breast at puberty, during pregnancy • and lactation, pregnant uterus, prostatic hyperplasia
  • 71. b) Compensatory hyperplasia i.e. hyperplasia occurring following removal of part of an organ or in the contralateral organ in paired organ e.g. i) Regeneration of the liver following partial hepatectomy. ii) Regeneration of epidermis after skin abrasion. iii) Following nephrectomy on one side, there is hyperplasia of nephrons of the other kidney
  • 72. 2. Pathologic hyperplasia-to excessive stimulation of hormones or growth factors e.g. i) Endometrial hyperplasia following estrogen excess. ii) Formation of skin warts from hyperplasia of epidermis due to human papilloma virus. iv) Pseudocarcinomatous hyperplasia of the skin occurring at the margin of a non-healing ulcer. v) Intraductal epithelial hyperplasia in fibrocystic change in the breast.
  • 73. Morphologic fx; There is enlargement of the affected organ or tissue and increase in the number of cells. This is due to increased rate of DNA synthesis and hence increased mitoses of the cells.
  • 74. 4. Metaplasia Metaplasia is a reversible change of one type of epithelial or mesenchymal adult cells to another type of adult epithelial or mesenchymal cells, usually in response to abnormal stimuli, and often reverts back to normal on removal of stimulus. Long duration persistent stimulus, epithelial metaplasia may progress to dysplasia and further into cancer.
  • 75. 2 types of metaplasia: •Epithelial •i) squamous metaplasia •ii) columnar metaplasia •Mesenchymal.
  • 76. • a)Epithelial metaplasia.-More common type. • The metaplastic change may be patchy or diffuse and usually results in replacement by stronger but less well specialized epithelium. Two types of epithelial metaplasia are seen: • squamous •columnar
  • 77. • 1. Squamous metaplasia; common-due to chronic irritation i.e mechanical, chemical or infective in origin. • Examples: • i) In bronchus (normally lined by pseudostratified columnar ciliated epithelium) in chronic smokers. • ii) In uterine endocervix (normally lined by simple columnar epithelium) in prolapse of the uterus and in old age. • iii) In gallbladder (normally lined by simple columnar epithelium) in chronic cholecystitis with cholelithiasis. • iv) In prostate (ducts normally lined by simple columnar epithelium) in chronic prostatitis and estrogen therapy.
  • 78. • Columnar metaplasia; There are some conditions in which there is transformation to columnar epithelium. E.g i) Intestinal metaplasia in healed chronic gastric ulcer ii) Columnar metaplasia in Barrett’s oesophagus, iii) Conversion of pseudostratified ciliated columnar epithelium in chronic bronchitis and bronchiectasis to columnar type. iv) In cervical erosion (congenital and adult type), there is variable area of endocervical glandular mucosa everted into the vagina.
  • 79.
  • 80. • b) Mesenchymal metaplasia-Less often, there is transformation of one adult type of mesenchymal tissue to another. • Example: • 1. Osseous metaplasia; Osseous metaplasia is formation of bone in fibrous tissue, cartilage and myxoid tissue. E.g • i) In arterial wall in old age (Mönckeberg’s medial calcific sclerosis) • ii) In cartilage of larynx and bronchi in elderly people • iii) In scar of chronic inflammation of prolonged duration • iv) In the fibrous stroma of tumor e.g. in leiomyoma.
  • 81. 5.Dysplasia • Dysplasia means ‘disordered cellular development’, often preceded or accompanied with metaplasia and hyperplasia; (atypical hyperplasia). • Dysplasia occurs most often in epithelial cells. • Dysplastic changes often occur due to chronic irritation or prolonged inflammation. On removal of the inciting stimulus, the changes may disappear. • Dysplasia may at times progress into carcinoma in situ.
  • 82. Assignment • Differences between Metaplasia and Dysplasia • Read about Ageing.